ArticleslgStudy

biology

Mogens Schou

Mogens Schou is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Mogens Schou rather than just read about it. In short: Mogens Schou (24 November 1918 – 29 September 2005) was a Danish psychiatrist whose research into lithium led to its utilization as a treatment for bipolar disorder. Early years Schou was born in Copenhagen, Denmark, on 24 November 1918.

Mogens Schou — main illustration
Mogens Schou — illustration

Key takeaways

  • Mogens Schou belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Mogens Schou to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Mogens Schou from memory before moving on to harder problems.

Reference excerpt

Mogens Schou (24 November 1918 – 29 September 2005) was a Danish psychiatrist whose research into lithium led to its utilization as a treatment for bipolar disorder.

Early years Schou was born in Copenhagen, Denmark, on 24 November 1918. His father was a psychiatrist and medical director of a large mental hospital. Schou chose to study medicine with a specific view to doing research on manic-depressive illness (now more commonly referred to as bipolar disorder). He graduated with a degree in medicine from the University of Copenhagen in 1944. After his training in clinical psychiatry he also studied experimental biology.

Research

Schou's research interests focused on therapeutic uses of lithium for patients with mood disorders. The psychopharmacological era began in earnest in 1949, with an article published by John Cade about the observed antimanic action of lithium in Australia. Intrigued by these findings Schou, who in the meantime had joined the Psychiatric Research Institute of Aarhus University, confirmed these findings in a double-blind placebo-controlled study with his co-workers in 1954. In a paper published in 1963, Mogens Schou introduced the term 'mood normalizer' or 'normothymotics' to categorize lithium, as it prevented episodes of depression or mania in bipolar disorder rather than just treating symptoms. Schou's younger brother suffered recurrent depressions that improved with lithium. During the early 1960s, G. P. Hartigan, Poul Chr. Baastrup and Schou independently made sporadic observations that were suggestive of lithium also having prophylactic properties in manic-depressive illness. Subsequently, Baastrup and Schou joined and in a non-blind lithium trial saw their preliminary observations confirmed. They even deemed the results so significant that they concluded that ‘lithium is the first drug demonstrated as a clear-cut prophylactic agent against one of the major psychoses’. However, the Schou-Baastrup prophylaxis hypothesis was met with great resistance by British psychiatry. To Aubrey Lewis and Michael Shepherd, lithium was ‘dangerous nonsense’. Shepherd, seconded by Harry Blackwell, simply characterized it as ‘a therapeutic myth’, which, in their opinion, was based on ‘serious methodological shortcomings’ and ‘spurious claims’. Even terms such as unethical and unscientific were used. After consideration of the ethical aspects invoked, Schou and Baastrup undertook a double-blind trial of prospective-discontinuation design and with random allocation of manic-depressive patients (already on lithium) to lithium or placebo. It confirmed their hypothesis, published in The Lancet in 1970. Schou was aware of some of the limitations of lithium treatment. He welcomed the introduction of other prophylactic agents into the market. From the available observations he concluded, however, that anti-epileptics and atypical anti-psychotics act on different kinds of bipolar patients to lithium. In 1988, Schou co-founded and was president of the International Group of Studies on Lithium Treated Patients (IGSLi). The group linked seven centers with clinical research programs on lithium. Before his death, Schou was concerned with three main tasks related to the further development of lithium. He called these tasks his 'Swan Song.' He was concerned with use of lithium in recurrent unipolar depressions for those with 'hidden' bipolar disorder, the use of lithium for its anti-suicidal properties, and the prevalence of lithium use for the prevention of episodes in bipolar disorder and recurrent depressions. He was an author of more than 500 publications, including texts, research papers, articles and book chapters. He was Emeritus Professor of the Psychiatric Hospital in Risskov, Denmark.

Awards and honors Schou has published approximately 540 works on lithium and lithium therapy, and some of his awards include:

1974—International Kittay Scientific Foundation Award (shared with Cade). 1982—John Cade Memorial Award. 1987—Albert Lasker Clinical Medical Research Award. 1995—International Society of Lithium Research's Mogens Schou Prize for Lifetime Achievement. 2000—C.I.N.P's Pioneers in Psychopharmacology Award. 2001—International Society For Bipolar Disorders Mogens Schou Award For Distinguished Contributions. 2004—NARSAD Lifetime Achievement Award. He has received an honorary doctorate from Charles University in Prague. In recognition of his accomplishments in bipolar medicine, he was made the Honorary President of the International Society for Bipolar Disorders. At the same time, the Mogens Schou awards were created for presentation at the Society's biennial International Conference on Bipolar Disorder. He was twice nominated for the Nobel Prize in Physiology or Medicine.

See also Lithium (medication) John Cade

References

Grof, Paul (2006). "Mogens Schou (1918–2005)". Neuropsychopharmacology. 31 (4): 891–892. doi:10.1038/sj.npp.1301018. Schioldann, Johan (23 March 2006). "Obituary Mogens Schou 1918–2005". Australasian Psychiatry. 14 (1): 116–117. doi:10.1111/j.1440-1665.2006.02239.x. Retrieved 2008-08-02.{{cite journal}}: CS1 maint: deprecated archival service (link) Obituary Mogens Schou

Illustrations

Mogens Schou illustration
Mogens Schou: Schou spent his life researching lithium as a treatment for mental illness
Schou spent his life researching lithium as a treatment for mental illness

Worked examples

Example 1 — a first encounter with Mogens Schou

Start with the simplest possible case. Write down what Mogens Schou claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Mogens Schou before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Mogens Schou ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Mogens Schou

In research
Mogens Schou appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Mogens Schou in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Mogens Schou is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1918 births, 2005 deaths, Bipolar disorder researchers, so understanding it makes those chapters shorter.
In everyday life
Look for Mogens Schou outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Mogens Schou” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Mogens Schou in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Mogens Schou means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Mogens Schou out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Mogens Schou in simple terms?

Mogens Schou (24 November 1918 – 29 September 2005) was a Danish psychiatrist whose research into lithium led to its utilization as a treatment for bipolar disorder. Early years Schou was born in Copenhagen, Denmark, on 24 November 1918.

Why does Mogens Schou matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Mogens Schou?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Mogens Schou.

Tags

  • 1918 births
  • 2005 deaths
  • Bipolar disorder researchers
  • Danish psychiatrists
  • Lithium in biology
  • Mood disorders
  • Psychiatry academics
  • Recipients of the Lasker–DeBakey Clinical Medical Research Award
  • Scientists from Copenhagen
  • University of Copenhagen alumni

Keep exploring